Glycopyrronium - Martindale Pharmaceuticals Ltd
Martindale
Description
Antimuscarinic bronchodilator.
For the treatment of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.
For the treatment of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.
Indications
For the maintenance treatment of COPD.
Contraindications
Avoid in the case of renal impairment, pregnancy or breast feeding.
Preparations Available
Solution for injection
Price
200 mcg/1 ml, 10 ampoules
600 mcg/3 ml, 10 ampoules
More on: Bronchodilators , Antimuscarinic bronchodilators